These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3768260)

  • 1. The pharmacokinetics of dapsone after oral administration to healthy volunteers.
    Pieters FA; Zuidema J
    Br J Clin Pharmacol; 1986 Oct; 22(4):491-4. PubMed ID: 3768260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of dapsone and acetylated dapsone in serum and saliva.
    Lammintausta K; Kangas L; Lammintausta R
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):159-63. PubMed ID: 447435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of effect of proguanil on the pharmacokinetics of dapsone in healthy volunteers.
    Edstein MD; Rieckmann KH
    Chemotherapy; 1993; 39(4):235-41. PubMed ID: 8325124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The absolute oral bioavailability of dapsone in dogs and humans.
    Pieters FA; Zuidema J
    Int J Clin Pharmacol Ther Toxicol; 1987 Jul; 25(7):396-400. PubMed ID: 3623744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetylation phenotyping using dapsone in a Jordanian population.
    Irshaid YM; al-Hadidi HF; Abuirjeie MA; Rawashdeh NM
    Br J Clin Pharmacol; 1991 Sep; 32(3):289-93. PubMed ID: 1777365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-acetylation polymorphism of dapsone in a Japanese population.
    Horai Y; Ishizaki T
    Br J Clin Pharmacol; 1988 Apr; 25(4):487-94. PubMed ID: 3382590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of age, sex and body weight on the dapsone acetylation phenotype.
    Philip PA; Gayed SL; Rogers HJ; Crome P
    Br J Clin Pharmacol; 1987 Jun; 23(6):709-13. PubMed ID: 3606931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-adipose administration of monoacetyldapsone to healthy volunteers.
    Pieters FA; Zuidema J
    Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):510-6. PubMed ID: 3819527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dapsone in saliva and plasma of man.
    Peters JH; Murray JF; Gordon GR; Gelber RH
    Pharmacology; 1981; 22(3):162-71. PubMed ID: 7208598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and protein binding interactions of dapsone and pyrimethamine.
    Ahmad RA; Rogers HJ
    Br J Clin Pharmacol; 1980 Nov; 10(5):519-24. PubMed ID: 7437265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of dapsone.
    Zuidema J; Hilbers-Modderman ES; Merkus FW
    Clin Pharmacokinet; 1986; 11(4):299-315. PubMed ID: 3530584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The disposition of dapsone and monoacetyldapsone in the dog (38516).
    Peters JH; Gordon R; Biggs JT; Levy L
    Proc Soc Exp Biol Med; 1975 Jan; 148(1):251-5. PubMed ID: 1129265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple-dose kinetics in healthy volunteers and in vitro antimalarial activity of proguanil plus dapsone.
    Edstein MD; Veenendaal JR; Rieckmann KH
    Chemotherapy; 1990; 36(3):169-76. PubMed ID: 2186899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphic acetylation of the antibacterials, sulfamethazine and dapsone, in South Indian subjects.
    Peters JH; Gordon GR; Karat AB
    Am J Trop Med Hyg; 1975 Jul; 24(4):641-8. PubMed ID: 1155699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood dapsone levels in leprosy patients treated with acedapsone.
    George J; Balakrishnan S
    Indian J Lepr; 1986; 58(3):401-6. PubMed ID: 3794408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple-dose pharmacokinetics and in vitro antimalarial activity of dapsone plus pyrimethamine (Maloprim) in man.
    Edstein MD; Rieckmann KH; Veenendaal JR
    Br J Clin Pharmacol; 1990 Aug; 30(2):259-65. PubMed ID: 2206787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of dapsone and monoacetyldapsone in rats.
    Gordon GR; Peters JH; Ghoul DC; Murray JF; Levy L; Biggs JT
    Proc Soc Exp Biol Med; 1975 Nov; 150(2):485-92. PubMed ID: 1208566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic observations on dapsone in dermatitis herpetiformis.
    Swain AF; Ahmad RA; Rogers HJ; Leonard JN; Fry L
    Br J Dermatol; 1983 Jan; 108(1):91-8. PubMed ID: 6821646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-acetylation phenotyping with dapsone in a mainland Chinese population.
    Horai Y; Zhou HH; Zhang LM; Ishizaki T
    Br J Clin Pharmacol; 1988 Jan; 25(1):81-7. PubMed ID: 3370194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma dapsone and its metabolite monoacetyldapsone levels in leprotic patients.
    Garg SK; Kumar B; Bakaya V; Lal R; Shukla VK; Kaur S
    Int J Clin Pharmacol Ther Toxicol; 1988 Nov; 26(11):552-4. PubMed ID: 3243659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.